Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATE IDA LATHROP

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1932382934
CMS profile
88192
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$18,030.59

  • Reported across 56 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$6,314.23

21 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $4,025.00 2
Travel and Lodging $1,246.67 3
Long term medical supply or device loan $797.60 8
Food and Beverage $244.96 8

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
TerSera Therapeutics LLC $3,341.67 5
NOVARTIS PHARMACEUTICALS CORPORATION $2,822.60 9
Daiichi Sankyo Inc. $69.27 3
Acerta Pharma LLC $42.96 2
Lilly USA, LLC $19.39 1
Gilead Sciences, Inc. $18.34 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,567.18 12
PY2019 $75.21 4
PY2020 $212.49 3
PY2021 $6,311.92 3
PY2022 $197.24 5
PY2023 $2,352.32 8
PY2024 $6,314.23 21

Payment records · PY2024 (21)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $21.18 01/17/2024 Food and Beverage Undisputed 01/23/2026 1104331724 CMS
AstraZeneca Pharmaceuticals LP $21.78 05/10/2024 Food and Beverage Undisputed 01/23/2026 1104407005 CMS
Daiichi Sankyo Inc. $28.17 05/06/2024 Food and Beverage Undisputed 01/23/2026 1089446970 CMS
Daiichi Sankyo Inc. $23.18 07/22/2024 Food and Beverage Undisputed 01/23/2026 1089446972 CMS
Daiichi Sankyo Inc. $17.92 10/14/2024 Food and Beverage Undisputed 01/23/2026 1089446968 CMS
Gilead Sciences, Inc. $18.34 11/06/2024 Food and Beverage Undisputed 01/23/2026 1133832720 CMS
Lilly USA, LLC $19.39 05/07/2024 Food and Beverage Undisputed 01/23/2026 1135092217 CMS
Novartis Pharmaceuticals Corporation $99.70 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087147196 CMS
Novartis Pharmaceuticals Corporation $99.70 02/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087147198 CMS
Novartis Pharmaceuticals Corporation $99.70 03/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087147200 CMS
Novartis Pharmaceuticals Corporation $99.70 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087147202 CMS
Novartis Pharmaceuticals Corporation $99.70 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087147204 CMS
Novartis Pharmaceuticals Corporation $99.70 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087147206 CMS
Novartis Pharmaceuticals Corporation $99.70 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087147208 CMS
Novartis Pharmaceuticals Corporation $99.70 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087147194 CMS
Novartis Pharmaceuticals Corporation $2,025.00 11/04/2024 Consulting Fee Undisputed 01/23/2026 1087147214 CMS
TerSera Therapeutics LLC $631.62 10/23/2024 Travel and Lodging Undisputed 01/23/2026 1144716219 CMS
TerSera Therapeutics LLC $95.00 10/23/2024 Food and Beverage Undisputed 01/23/2026 1144716221 CMS
TerSera Therapeutics LLC $119.10 10/23/2024 Travel and Lodging Undisputed 01/23/2026 1144716223 CMS
TerSera Therapeutics LLC $495.95 10/23/2024 Travel and Lodging Undisputed 01/23/2026 1144716225 CMS
TerSera Therapeutics LLC $2,000.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 1144716227 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.